Merck Tbk PT

Merck Tbk PT Net Margin

The Net Profit Margin of Merck Tbk PT (MERK.JK) as of Oct 17, 2026 is 20.31 %. In the previous year, Net Profit Margin was 14.80 % — a change of 37.23% (higher).

Net Margin

20.31 %

YoY

37.23%

Last updated:

Net Profit Margin of Merck Tbk PT is 2025 20.31 % . Net Profit Margin of Merck Tbk PT was 2024 14.80 % . It decreases by 37.23% higher compared to the previous year.

For Merck Tbk PT, the net margin of 20.3% is up versus 12.4% a few years ago.

The Merck Tbk PT Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
190.10 IDR
Jan 1, 2019
10.51 IDR
Jan 1, 2020
10.96 IDR
Jan 1, 2021
12.37 IDR
Jan 1, 2022
15.99 IDR
Jan 1, 2023
18.54 IDR
Jan 1, 2024
14.80 IDR
Jan 1, 2025
20.31 IDR
The Merck Tbk PT Net Margin history
YEARNet MarginYoY
20.31 %+37.23%
14.80 %-20.16%
18.54 %+15.93%
15.99 %+29.28%
12.37 %+12.83%
10.96 %+4.32%
10.51 %-94.47%
190.10 %+1,419.78%
12.51 %-15.86%
14.87 %+2.57%
14.49 %-31.05%
21.02 %+14,206.77%
0.15 %+26.74%
0.12 %-53.93%
0.25 %+68.56%
0.15 %-23.53%
0.20 %+26.13%
0.15 %-5.34%
0.16 %-7.86%
0.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT is a pharmaceutical company based in Jakarta Timur, DKI Jakarta, operating within the Health Care sector. The company, listed on the Indonesian stock exchange with ticker MERK.JK and ISIN ID1000136609, has been publicly traded since its IPO on July 23, 1981. It employs 376 full-time staff and focuses on the development and distribution of pharmaceutical and chemical products. The company operates through three business segments: Biopharma, which covers ethical pharmaceutical products; Consumer Health, which includes over-the-counter products; and Others, which encompasses additional business activities. Merck Tbk PT is committed to providing personalized treatments for serious diseases and supports initiatives related to reproductive health, including enabling individuals to achieve their goal of becoming parents. The company's official website is https://www.merckgroup.com/id-id, where further information about its operations and services can be accessed. As a publicly listed entity, Merck Tbk PT is subject to regulatory disclosures and financial reporting requirements in Indonesia. The company's primary focus remains on delivering healthcare solutions through its pharmaceutical and chemical offerings, targeting both professional medical markets and consumer health needs. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

Net Profit Margin of Merck Tbk PT is 20.31 % in 2025.

Net Profit Margin of Merck Tbk PT changed from 14.80 % to 20.31 %, representing a 37.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Merck Tbk PT with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Merck Tbk PT

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Merck Tbk PT